Self-harm, such as self-cutting, self-poisoning or jumping from height, regardless of intentions, is common among people with schizophrenia. We wished to investigate brain activations relating to self-harm, in order to test whether these activations could differentiate between schizophrenia patients with self-harm and those without. We used event-related functional MRI with a go/no-go response inhibition paradigm. Fourteen schizophrenia patients with a history of self-harm were compared with 14 schizophrenia patients without a history of self-harm and 17 healthy control participants. In addition, we used standard clinical measures and neuropsychological tests to assess risk factors associated with self-harm. The right dorsolateral prefrontal cortex (DLPFC) and the left posterior cingulate cortex differentiated all three groups; brain activation in these regions being greatest in the control group, and the self-harm patient group being greater than in the non-self-harm patient group. In the self-harm patient group, right DLPFC activity was positively correlated with severity of suicidal thinking. In addition, both patient groups showed less activation in the right orbitofrontal cortex, left ventral anterior cingulate cortex and right thalamus. This is the first study to report right DLPFC activation in association with self-harm and suicidal thinking in patients with schizophrenia. This area could be a target for future neuromodulation studies to treat suicidal thinking and self-harm behaviors in patients with schizophrenia.
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Introduction
Self-harm is a significant risk factor for later completed suicide: previous self-harm carries an eightfold increase for completed suicide in patients with schizophrenia. Systematic reviews have indicated that clinical features associated with suicide in patients with schizophrenia include depressive episodes, previous suicide attempts, and substance abuse (Hawton et al., 2005; Hor and Taylor, 2010) . Other risk factors associated with suicide attempts included high impulsivity, relatively preserved executive cognitive functions, and good insight into their illness (Kim et al., 2003) . Iancu and colleagues have highlighted the importance of impulsivity associated with suicide attempts and ideation in patients with schizophrenia (Iancu et al., 2010) . They showed that a high implusivity group, compared with a low implusivity group, had higher scores on suicide ideation scores and more lifetime suicide attempts. High impulsivity is particularly linked to schizophrenia patients who have clinical histories involving both suicide attempts and nonsuicidal self-harming acts (Mork et al., 2013) . In our recent study, we identified impulsivity as one of five significant factors that differentiated schizophrenia patients with self-harm from those without (Pluck et al., 2013) .
Although the prefrontal cortex has been implicated in self-harm in depression, the neural basis of mental processes associated with suicide risk in patients with schizophrenia is not well studied. Neuroimaging studies have revealed reduced glucose metabolism in the prefrontal cortex in depressive patients with high-lethality suicide attempts compared to those with low-lethality attempts (Oquendo et al., 2003) . Depression patients who completed suicide, compared with non-suicidal depression patients, had significantly higher regional cerebral blood flow (rCBF) in the right hemisphere (Amen et al., 2009) . Consistent with this, Hunter and colleagues reported increased right prefrontal EEG coherence when patients with depression experienced worsening of suicidal ideation and mood symptoms during anti-depressant treatment (Hunter et al., 2010) . Further, in patients with depression, high levels of mental pain associated with suicide were related to increased rCBF in the right dorsolateral prefrontal cortex (van Heeringen et al., 2010) . These activations are generally consistent with observations that schizophrenia patients who attempt suicide have better prefrontal
